Reduced Burden of Oncologic Therapy in Children, Adolescents and Young Adults with Good Risk (GR) CD20+Mature B-Cell Lymphoma

Authors

Stan Goldman
Matthew Barth
Jessica Hochberg, New York Medical CollegeFollow
Liana Klejmont, New York Medical CollegeFollow
Lauren Harrison, New York Medical CollegeFollow
Qiuhu Shi, New York Medical CollegeFollow
Javier Oesterheld
Kenneth Heym
Sherrie Perkins
Rodney Miles
Bruce Shiramizu
Mitchell Cairo, New York Medical CollegeFollow

Document Type

Abstract

Publication Date

9-2018

Journal Title

British Journal of Haematology

Department

Medicine

Second Department

Public Health

Third Department

Health Behavior and Community Health

Recommended Citation

Goldman, S., Barth, M., Hochberg, J., Klejmont, L., Harrison, L., Shi, Q., Oesterheld, J., Heym, K., Perkins, S., Miles, R., Shiramizu, B., & Cairo, M. (2018). Reduced Burden of Oncologic Therapy in Children, Adolescents and Young Adults with Good Risk (GR) CD20+Mature B-Cell Lymphoma. British Journal of Haematology, 182 (Suppl. 1), 11. https://doi.org/10.1111/bjh.15536